One moment, please...
ansunbiopharma.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$167.1M
3 rounds on record
Latest round
$100M
Venture round · Jul 2019 · 7 yr ago
Team
9
US Form 5500 (plan participants) · Dec 2024
Backers
1
LAV
The money's age
Long since its last round
86 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 17, 2019
Raised a round Venture round $100M · SEC Form D
Apr 19, 2018
Raised a round Venture round $67.1M · SEC Form D
Feb 24, 2017
Took on debt financing $1.7M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2019 | $100M | — | SEC Form D |
| Venture round | Apr 2018 | $67.1M | — | SEC Form D |
| Debt Financing | Feb 2017 | $1.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ANSUN BIOPHARMA, INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Nancy ChangExecutive Officer, DirectorSEC Form D
Michael HavluciyanExecutive OfficerSEC Form D
Mikael HavluciyanExecutive OfficerSEC Form D
Yining ZhaoExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
LAV People
Nancy Chang
Executive Officer, Director
Michael Havluciyan
Executive Officer
Mikael Havluciyan
Executive Officer
Yining Zhao
Executive Officer
Michael Chang
Director
Allen Chao
Director
Michael Chao
Director
Aimin Wu
Director
Yi Shi
Director
Dave Chenn
Director
Karen Liu
Director
Donald Payne
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ